4 Results Found

Advanced Search

Select all

Results per page

Select all

Article

3 Citations

4,034 Views

13 Pages

Factors Associated with Non-Adherence to Tuberculosis Preventive Treatment among Adult Contacts of Pulmonary Tuberculosis Cases with Latent Tuberculosis Infection in Catalonia, Spain, in 2019−2021

Pedro Plans-Rubió,
Sofia Godoy,
Diana Toledo,
Angela Domínguez,
Joan Caylà,
Ignasi Parron,
Joan Pau Millet and
Pere Godoy

Trop. Med. Infect. Dis.2024, 9(3), 54;https://doi.org/10.3390/tropicalmed9030054

27 February 2024

The aim of this study was to identify factors associated with non-adherence to tuberculosis (TB) preventive treatment among contacts with latent TB infection for new cases of pulmonary TB cases reported in Catalonia in 2019–2021. All contacts a...

Full Article

Article

1 Citations

1,576 Views

9 Pages

Losses in the Care Cascade for Latent Tuberculosis Infection in the Tracing Contact Studies

Sofia Godoy,
Ignasi Parrón,
Joan-Pau Millet,
Joan A. Caylà,
Núria Follia,
Mònica Carol,
Àngels Orcau,
Miquel Alsedà,
Diana Toledo and
the Transmission of Tuberculosis in Catalonia (Spain) Working Group
+ 6 authors

Pathogens2023, 12(12), 1403;https://doi.org/10.3390/pathogens12121403

29 November 2023

Background: The control of latent tuberculosis infection (LTBI) encompasses multiple stages. The objective was to calculate the losses in the LTBI care cascade for pulmonary TB contacts in Catalonia (Spain). Methods: The LTBI care cascade was studied...

Full Article

Article

5 Citations

2,329 Views

12 Pages

Latent Tuberculosis: A Promising New Compound to Treat Non-Replicating and Intramacrophagic Mycobacteria

Débora Leite Campos,
Fernanda Manaia Demarqui,
Mariana Cristina Solcia,
Paula Carolina de Souza,
Pedro Ivo da Silva Maia,
Victor Marcelo Deflon and
Fernando Rogério Pavan

Biomedicines2022, 10(10), 2398;https://doi.org/10.3390/biomedicines10102398

26 September 2022

As a biologic reservoir of Mycobacterium tuberculosis (M. tb), one-quarter of the world population is infected with the well-known latent tuberculosis (LTBI). About 5–10% of LTBI patients will progress to active disease in the first years after...

Full Article

Review

20 Citations

8,191 Views

38 Pages

Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection

Kai Ling Chin,
Luis Anibarro,
Maria E. Sarmiento and
Armando Acosta

Trop. Med. Infect. Dis.2023, 8(2), 89;https://doi.org/10.3390/tropicalmed8020089

28 January 2023

Globally, it is estimated that one-quarter of the world’s population is latently infected with Mycobacterium tuberculosis (Mtb), also known as latent tuberculosis infection (LTBI). Recently, this condition has been referred to as tuberculosis i...

Full Article